Antigens recognized by T-lymphocytes on human tumours

被引：19

作者：

Coulie, PG ^{[1
]}

VandenEynde, BJ ^{[1
]}

vanderBruggen, P ^{[1
]}

VanPel, A ^{[1
]}

Boon, T ^{[1
]}

机构：

[1] LUDWIG INST CANC RES,B-1200 BRUSSELS,BELGIUM

来源：

BIOCHEMICAL SOCIETY TRANSACTIONS | 1997年 / 25卷 / 02期

关键词：

D O I：

10.1042/bst0250544

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：544 / 548

页数：5

共 40 条

[1] MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100 IS RECOGNIZED BY MELANOMA-DERIVED TUMOR-INFILTRATING LYMPHOCYTES [J].

BAKKER, ABH ;

SCHREURS, MWJ ;

DEBOER, AJ ;

KAWAKAMI, Y ;

ROSENBERG, SA ;

ADEMA, GJ ;

FIGDOR, CG .

JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :1005-1009

[2] BAGE - A NEW GENE ENCODING AN ANTIGEN RECOGNIZED ON HUMAN MELANOMAS BY CYTOLYTIC T-LYMPHOCYTES [J].

BOEL, P ;

WILDMANN, C ;

SENSI, ML ;

BRASSEUR, R ;

RENAULD, JC ;

COULIE, P ;

BOON, T ;

VANDERBRUGGEN, P .

IMMUNITY, 1995, 2 (02) :167-175

[3] A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma [J].

Brandle, D ;

Brasseur, F ;

Weynants, P ;

Boon, T ;

VandenEynde, BJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2501-2508

[4] EXPRESSION OF MAGE GENES IN PRIMARY AND METASTATIC CUTANEOUS MELANOMA [J].

BRASSEUR, F ;

RIMOLDI, D ;

LIENARD, D ;

LETHE, B ;

CARREL, S ;

ARIENTI, F ;

SUTER, L ;

VANWIJCK, R ;

BOURLOND, A ;

HUMBLET, Y ;

VACCA, A ;

CONESE, M ;

LAHAYE, T ;

DEGIOVANNI, G ;

DERAEMAECKER, R ;

BEAUDUIN, M ;

SASTRE, X ;

SALAMON, E ;

DRENO, B ;

JAGER, E ;

KNUTH, A ;

CHEVREAU, C ;

SUCIU, S ;

LACHAPELLE, JM ;

POUILLART, P ;

PARMIANI, G ;

LEJEUNE, F ;

CEROTTINI, JC ;

BOON, T ;

MARCHAND, M .

INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (03) :375-380

[5] HUMAN GENE MAGE-1, WHICH CODES FOR A TUMOR-REJECTION ANTIGEN, IS EXPRESSED BY SOME BREAST-TUMORS [J].

BRASSEUR, F ;

MARCHAND, M ;

VANWIJCK, R ;

HERIN, M ;

LETHE, B ;

CHOMEZ, P ;

BOON, T .

INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (05) :839-841

[6] THE TYROSINASE GENE CODES FOR AN ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS [J].

BRICHARD, V ;

VANPEL, A ;

WOLFEL, T ;

WOLFEL, C ;

DEPLAEN, E ;

LETHE, B ;

COULIE, P ;

BOON, T .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :489-495

[7] A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes [J].

Brichard, VG ;

Herman, J ;

VanPel, A ;

Wildmann, C ;

Gaugler, B ;

Wolfel, T ;

Boon, T ;

Lethe, B .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :224-230

[8] PROGNOSTIC-SIGNIFICANCE OF HYPOPIGMENTATION IN MALIGNANT-MELANOMA [J].

BYSTRYN, JC ;

RIGEL, D ;

FRIEDMAN, RJ ;

KOPF, A .

ARCHIVES OF DERMATOLOGY, 1987, 123 (08) :1053-1055

[9] MASS-SPECTROMETRIC IDENTIFICATION OF A NATURALLY PROCESSED MELANOMA PEPTIDE RECOGNIZED BY CD8(+) CYTOTOXIC T-LYMPHOCYTES [J].

CASTELLI, C ;

STORKUS, WJ ;

MAEURER, MJ ;

MARTIN, DM ;

HUANG, EC ;

PRAMANIK, BN ;

NAGABHUSHAN, TL ;

PARMIANI, G ;

LOTZE, MT .

JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :363-368

[10]

CHOMEZ P, 1995, IMMUNOGENETICS, V43, P97

← 1 2 3 4 →